Common Stock, Shares, Outstanding of Cellectar Biosciences, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cellectar Biosciences, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Cellectar Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 4,240,129, a 176% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Cellectar Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 4,240,129 +2,704,133 +176% 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q3 2025 3,192,040 -37,374,494 -92% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 1,812,040 -34,036,884 -95% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 46,079,875 +12,915,409 +39% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 1,535,996 -19,208,114 -93% 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q3 2024 40,566,534 +30,648,150 +309% 30 Sep 2024 10-Q 18 Nov 2024 2024 Q3
Q2 2024 35,848,924 +26,108,417 +268% 30 Jun 2024 10-Q 29 Oct 2024 2024 Q2
Q1 2024 33,164,466 +23,423,959 +240% 31 Mar 2024 10-Q/A 29 Oct 2024 2024 Q1
Q4 2023 20,744,110 +11,358,838 +121% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 9,918,384 +3,808,266 +62% 30 Sep 2023 10-K/A 29 Oct 2024 2023 FY
Q2 2023 9,740,507 +3,630,385 +59% 30 Jun 2023 10-K/A 29 Oct 2024 2023 FY
Q1 2023 9,740,507 +3,630,383 +59% 31 Mar 2023 10-K/A 29 Oct 2024 2023 FY
Q4 2022 9,385,272 +3,275,147 +54% 31 Dec 2022 10-K/A 29 Oct 2024 2023 FY
Q3 2022 6,110,118 -54,991,146 -90% 30 Sep 2022 10-K/A 29 Oct 2024 2023 FY
Q2 2022 6,110,122 -49,157,809 -89% 30 Jun 2022 10-K/A 29 Oct 2024 2023 FY
Q1 2022 6,110,124 -46,616,154 -88% 31 Mar 2022 10-K/A 29 Oct 2024 2023 FY
Q4 2021 6,110,125 -39,332,604 -87% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 61,101,264 +34,287,671 +128% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 55,267,931 +29,795,548 +117% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 52,726,278 +43,330,263 +461% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 45,442,729 +36,056,040 +384% 31 Dec 2020 10-K 21 Mar 2022 2021 FY
Q3 2020 26,813,593 +17,426,890 +186% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 25,472,383 +16,085,680 +171% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 9,396,015 +4,309,306 +85% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 9,386,689 +4,654,302 +98% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 9,386,703 +5,116,714 +120% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 9,386,703 +7,611,711 +429% 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 5,086,709 -12,014,967 -70% 31 Mar 2019 10-Q 06 May 2019 2019 Q1
Q4 2018 4,732,387 +3,066,243 +184% 31 Dec 2018 10-K 09 Mar 2020 2019 FY
Q3 2018 4,269,989 -9,207,181 -68% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 1,774,992 -11,687,178 -87% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 17,101,676 +3,643,506 +27% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 1,666,144 -8,702,181 -84% 31 Dec 2017 10-K 26 Feb 2019 2018 FY
Q3 2017 13,477,170 +8,108,935 +151% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 13,462,170 +8,093,935 +151% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 13,458,170 +12,600,157 +1469% 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 10,368,325 +9,510,185 +1108% 31 Dec 2016 10-K 21 Mar 2018 2017 FY
Q3 2016 5,368,235 -2,195,898 -29% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 5,368,235 -2,194,527 -29% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 858,013 -6,704,749 -89% 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 858,140 +101,864 +13% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 7,564,133 +1,371 +0.02% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 7,562,762 +4,693,023 +164% 30 Jun 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 7,562,762 -49,835,235 -87% 31 Mar 2015 10-Q 20 May 2015 2015 Q1
Q4 2014 756,276 -2,113,463 -74% 31 Dec 2014 10-K/A 20 Oct 2016 2015 FY
Q3 2014 7,562,762 -49,835,235 -87% 30 Sep 2014 10-Q 20 May 2015 2014 Q3
Q2 2014 2,869,739 -54,528,258 -95% 30 Jun 2014 10-Q 04 Aug 2014 2014 Q2
Q1 2014 57,397,997 0 0% 31 Mar 2014 10-Q 14 May 2014 2014 Q1
Q4 2013 2,869,739 -43,528,258 -94% 31 Dec 2013 10-K 20 May 2015 2014 FY
Q3 2013 57,397,997 +13,937,500 +32% 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 57,397,997 +14,211,997 +33% 30 Jun 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 57,397,997 +20,435,733 +55% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 46,397,997 +9,490,173 +26% 31 Dec 2012 10-K 19 Mar 2014 2013 FY
Q3 2012 43,460,497 +16,634,340 +62% 30 Sep 2012 10-Q 06 Nov 2012 2012 Q3
Q2 2012 43,186,000 +16,359,843 +61% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 36,962,264 31 Mar 2012 10-Q 04 May 2012 2012 Q1
Q4 2011 36,907,824 +24,087,722 +188% 31 Dec 2011 10-K 28 Mar 2013 2012 FY
Q3 2011 26,826,157 30 Sep 2011 10-Q 07 Nov 2011 2011 Q3
Q2 2011 26,826,157 30 Jun 2011 10-Q 12 Aug 2011 2011 Q2
Q4 2010 12,820,102 31 Dec 2010 10-K 09 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.